PureHealth Q2 2026 earnings forecasts

Pure Health logo

Argaam, in this report, provides an overview of PureHealth expected results for Q2 2026 along with trends in quarterly revenue and earnings, in addition to key operating and profitability indicators.

Quarterly Revenue – AED mln

Quarterly Earnings– AED mln

* Operating expense grant income of AED 437.4 million, capital expenditure grant income of AED 43.5 million, reversal of management incentives amounting to AED 42.5 million, and a gain of AED 12.2 million from the disposal of property and equipment.

Key events in Q2 2026

Shareholders approved a cash dividend of AED 0.0541 per share for 2025.

The company inaugurated a campus for the University of Nicosia in Athens, Greece, in the presence of senior officials. The campus will offer medical education integrating artificial intelligence with clinical training. The initiative aims to strengthen UAE-Greece cooperation, help address Europe's healthcare workforce shortage by linking academic education with scientific research and provide exchange and practical training programs.

The company announced that its insurance arm, Daman, received an A1 Insurance Financial Strength Rating from Moody's Ratings with a stable outlook, the highest rating among insurers in the UAE and the GCC. The rating reflects the company's financial strength and the successful transformation of Daman into a comprehensive and sustainable insurance platform.

Average forecasts

The company is forecast to report a net profit of AED 394.8 million, 24% lower year-on-year (YoY), according to the average estimates of two research houses.

Average estimates – AED mln

Stock performance